https://www.woutermeijers.nl/publications/meijers-wc-maglione-m-bakker-sjl-et-al-heart-failure-stimulates-tumor-growth-by-circulating-factors-circulation-20181387678-691-doi10-1161-circulationaha-117-030816/2026-09-18T22:02:49+02:00https://www.woutermeijers.nl/publications/994/2026-09-18T22:07:17+02:00https://www.woutermeijers.nl/publications/995/2026-09-18T22:07:44+02:00https://www.woutermeijers.nl/publications/996/2026-09-18T22:08:23+02:00https://www.woutermeijers.nl/publications/997/2026-09-18T22:08:48+02:00https://www.woutermeijers.nl/publications/meijers-wc-bayes-genis-a-mebazaa-a-et-al-circulating-heart-failure-biomarkers-beyond-natriuretic-peptides-review-from-the-biomarker-study-group-of-the-heart-failure-association-hfa-european-so/2026-09-18T22:11:45+02:00https://www.woutermeijers.nl/publications/meijers-wc-bayes-genis-a-mebazaa-a-et-al-circulating-heart-failure-biomarkers-beyond-natriuretic-peptides-review-from-the-biomarker-study-group-of-the-heart-failure-association-hfa-european-so-2/2026-09-18T22:12:19+02:00https://www.woutermeijers.nl/publications/axelrod-ml-meijers-wc-screever-em-et-al-t-cells-specific-for-%ce%b1-myosin-drive-immunotherapy-related-myocarditis-nature-20226117937818-826-doi10-1038-s41586-022-05432-3/2026-09-18T22:10:04+02:00https://www.woutermeijers.nl/publications/screever-em-gorter-tm-willems-tp-et-al-diffuse-myocardial-fibrosis-on-cardiac-magnetic-resonance-imaging-is-related-to-galectin-3-and-predicts-outcome-in-heart-failure-biomolecules-202313341/2026-09-18T22:13:10+02:00https://www.woutermeijers.nl/publications/yousif-li-screever-em-versluis-d-et-al-risk-factors-for-immune-checkpoint-inhibitor-mediated-cardiovascular-toxicities-curr-oncol-rep-2023257753-763-doi10-1007-s11912-023-01414-4/2026-09-18T22:13:27+02:00https://www.woutermeijers.nl/publications/screever-em-yousif-lie-moslehi-jj-et-al-circulating-immune-checkpoints-predict-heart-failure-outcomes-esc-heart-fail-20231042330-2337-doi10-1002-ehf2-14304/2026-09-18T22:14:01+02:00https://www.woutermeijers.nl/publications/van-den-berg-pf-aboumsallem-jp-screever-em-et-al-fibrotic-marker-galectin-3-identifies-males-at-risk-of-developing-cancer-and-heart-failure-jacc-cardiooncol-202354445-453-published-2023-jul/2026-09-18T22:14:21+02:00https://www.woutermeijers.nl/publications/salloum-fn-tocchetti-cg-ameri-p-et-al-priorities-in-cardio-oncology-basic-and-translational-science-gcos-2023-symposium-proceedings-jacc-cardiooncology-state-of-the-art-review-jacc-cardiooncol/2026-09-18T22:14:36+02:00https://www.woutermeijers.nl/publications/koop-y-yousif-l-de-boer-ra-bots-ml-meijers-wc-vaartjes-i-dutch-cardio-oncology-cohort-incident-cardiovascular-disease-predisposes-to-a-higher-cancer-mortality-rate-eur-j-clin-invest-2024549/2026-09-18T22:15:03+02:00https://www.woutermeijers.nl/publications/van-den-berg-pf-yousif-li-markousis-mavrogenis-g-et-al-hallmarks-of-cancer-in-patients-with-heart-failure-data-from-biostat-chf-cardiooncology-202410147-published-2024-aug-5-doi10-1186-s/2026-09-18T22:16:00+02:00https://www.woutermeijers.nl/publications/van-den-berg-pf-bracun-v-noordman-m-et-al-elevations-of-cardiac-troponin-in-patients-receiving-immune-checkpoint-inhibitors-data-from-a-prospective-study-jacc-adv-2024312101375-published-2/2026-09-18T22:16:26+02:00https://www.woutermeijers.nl/publications/appels-y-yousif-li-pieters-cs-de-boer-ra-aboumsallem-jp-meijers-wc-cardiotoxicity-beyond-cardiomyocytes-focus-on-the-role-of-cardiac-fibroblasts-and-endothelial-cells-heart-lung-circ-2025346/2026-09-18T22:16:38+02:00https://www.woutermeijers.nl/publications/cagnazzo-r-stabile-m-zoppoli-g-et-al-mismatch-between-preclinical-cardio-oncology-and-clinical-oncology-research-jacc-cardiooncol-202576770-773-doi10-1016-j-jaccao-2025-05-012/2026-09-18T22:17:00+02:00https://www.woutermeijers.nl/publications/camilli-m-goncalves-t-meijers-wc-the-next-generation-of-cardio-oncologists-eur-heart-j-202546363513-3514-doi10-1093-eurheartj-ehaf452/2026-09-18T22:17:27+02:00https://www.woutermeijers.nl/publications/de-boer-ra-yousif-li-aboumsallem-jp-meijers-wc-current-insights-in-bidirectional-cardio-oncology-heart-failure-driving-cancer-jacc-cardiooncology-short-form-primer-jacc-cardiooncol-202575/2026-09-18T22:17:44+02:00https://www.woutermeijers.nl/publications/yousif-li-sijtema-ag-appels-y-et-al-the-immune-checkpoint-tim-3-hmgb-1-axis-in-myocardial-infarction-npj-cardiovasc-health-20252132-doi10-1038-s44325-025-00061-x/2026-09-18T22:17:54+02:00https://www.woutermeijers.nl/publications/meijers-wc-aboumsallem-jp-lyon-ar-moslehi-j-de-boer-ra-forward-and-reverse-cardio-oncology-physiol-rev-20261061587-644-doi10-1152-physrev-00041-2024/2026-09-18T22:18:06+02:00https://www.woutermeijers.nl/publications/van-den-berg-pf-yousif-li-koop-y-et-al-framingham-risk-score-associates-with-incident-cancer-and-heart-failure-eur-j-prev-cardiol-2026334490-497-doi10-1093-eurjpc-zwaf618/2026-09-18T22:18:25+02:00https://www.woutermeijers.nl/publications/yousif-li-sijtema-ag-appels-y-et-al-pd-1-pd-l1-signaling-in-non-ici-myocarditis-jacc-basic-transl-sci-2026118101539-doi10-1016-j-jacbts-2026-101539/2026-09-18T22:18:48+02:00https://www.woutermeijers.nl/publications/ameri-p-madonna-r-costa-a-et-al-quality-standards-for-preclinical-research-in-cardio-oncology-eur-heart-j-published-online-september-7-2026-doi10-1093-eurheartj-ehag609/2026-09-18T22:22:16+02:00